Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00493467
Status:
COMPLETED
Last Update Posted:
2022-09-15
First Post:
2007-06-27
Brief Title:
Zevalin Ibritumomab Tiuxetan for Early Stage Indolent Lymphomas
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center